Palmitate-Induced Cardiac Lipotoxicity Is Relieved by the Redox-Active Motif of SELENOT through Improving Mitochondrial Function and Regulating Metabolic State.
antioxidants
cardiomyocyte
lipotoxicity
peptides
selenoproteins
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
29 03 2023
29 03 2023
Historique:
received:
24
02
2023
revised:
22
03
2023
accepted:
27
03
2023
medline:
14
4
2023
entrez:
13
4
2023
pubmed:
14
4
2023
Statut:
epublish
Résumé
Cardiac lipotoxicity is an important contributor to cardiovascular complications during obesity. Given the fundamental role of the endoplasmic reticulum (ER)-resident Selenoprotein T (SELENOT) for cardiomyocyte differentiation and protection and for the regulation of glucose metabolism, we took advantage of a small peptide (PSELT), derived from the SELENOT redox-active motif, to uncover the mechanisms through which PSELT could protect cardiomyocytes against lipotoxicity. To this aim, we modeled cardiac lipotoxicity by exposing H9c2 cardiomyocytes to palmitate (PA). The results showed that PSELT counteracted PA-induced cell death, lactate dehydrogenase release, and the accumulation of intracellular lipid droplets, while an inert form of the peptide (I-PSELT) lacking selenocysteine was not active against PA-induced cardiomyocyte death. Mechanistically, PSELT counteracted PA-induced cytosolic and mitochondrial oxidative stress and rescued SELENOT expression that was downregulated by PA through FAT/CD36 (cluster of differentiation 36/fatty acid translocase), the main transporter of fatty acids in the heart. Immunofluorescence analysis indicated that PSELT also relieved the PA-dependent increase in CD36 expression, while in SELENOT-deficient cardiomyocytes, PA exacerbated cell death, which was not mitigated by exogenous PSELT. On the other hand, PSELT improved mitochondrial respiration during PA treatment and regulated mitochondrial biogenesis and dynamics, preventing the PA-provoked decrease in PGC1-α and increase in DRP-1 and OPA-1. These findings were corroborated by transmission electron microscopy (TEM), revealing that PSELT improved the cardiomyocyte and mitochondrial ultrastructures and restored the ER network. Spectroscopic characterization indicated that PSELT significantly attenuated infrared spectral-related macromolecular changes (i.e., content of lipids, proteins, nucleic acids, and carbohydrates) and also prevented the decrease in membrane fluidity induced by PA. Our findings further delineate the biological significance of SELENOT in cardiomyocytes and indicate the potential of its mimetic PSELT as a protective agent for counteracting cardiac lipotoxicity.
Identifiants
pubmed: 37048116
pii: cells12071042
doi: 10.3390/cells12071042
pmc: PMC10093731
pii:
doi:
Substances chimiques
Palmitates
0
Fatty Acids
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Front Oncol. 2019 Aug 07;9:615
pubmed: 31440463
EMBO Rep. 2017 Nov;18(11):1935-1946
pubmed: 28928140
Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3077-82
pubmed: 12629214
J Biomed Sci. 2014 Feb 12;21:13
pubmed: 24521082
Curr Heart Fail Rep. 2013 Jun;10(2):109-21
pubmed: 23508767
Biosci Rep. 2019 May 21;39(5):
pubmed: 31064816
Circ Res. 2012 Mar 2;110(5):764-76
pubmed: 22383711
J Biol Chem. 2013 Mar 8;288(10):7117-26
pubmed: 23329830
Exp Mol Med. 2017 Feb 3;49(2):e291
pubmed: 28154371
Acta Physiol (Oxf). 2021 Apr;231(4):e13570
pubmed: 33073482
Mol Biol Evol. 2020 Feb 1;37(2):341-354
pubmed: 31560400
FASEB J. 2019 Jun;33(6):7734-7747
pubmed: 30973759
Cardiovasc Toxicol. 2020 Apr;20(2):139-154
pubmed: 31278615
Endocrinology. 2013 Oct;154(10):3796-806
pubmed: 23913443
Circ Res. 1991 Dec;69(6):1476-86
pubmed: 1683272
Antioxidants (Basel). 2022 Mar 17;11(3):
pubmed: 35326221
Nutrients. 2021 Nov 14;13(11):
pubmed: 34836326
Science. 2012 Aug 31;337(6098):1062-5
pubmed: 22936770
PLoS One. 2018 Jan 12;13(1):e0191313
pubmed: 29329354
Circ Res. 2018 Jan 5;122(1):58-73
pubmed: 29092894
Redox Biol. 2022 Jun;52:102320
pubmed: 35462320
Mol Cell Biochem. 2012 May;364(1-2):19-28
pubmed: 22203421
Antioxidants (Basel). 2020 Aug 02;9(8):
pubmed: 32748857
PLoS One. 2016 Jan 12;11(1):e0145750
pubmed: 26756466
Int J Mol Sci. 2021 Apr 28;22(9):
pubmed: 33924958
Circulation. 2021 May 25;143(21):e984-e1010
pubmed: 33882682
Biomed Pharmacother. 2020 Aug;128:110306
pubmed: 32526458
Nutr J. 2016 Jul 25;15(1):71
pubmed: 27456681
Redox Biol. 2016 Aug;8:216-25
pubmed: 26826574
Analyst. 2010 Dec;135(12):3094-102
pubmed: 20978686
Biochim Biophys Acta. 2008 Nov-Dec;1781(11-12):685-93
pubmed: 18755291
Obes Res Clin Pract. 2014 Nov-Dec;8(6):e540-8
pubmed: 25434909
Cardiovasc Res. 2008 Jan 15;77(2):334-43
pubmed: 18006487
PLoS One. 2015 Jun 29;10(6):e0129303
pubmed: 26121149
Int J Mol Sci. 2021 Sep 10;22(18):
pubmed: 34575980
Antioxid Redox Signal. 2007 Dec;9(12):2277-93
pubmed: 17979528
Am J Physiol Heart Circ Physiol. 2019 Mar 1;316(3):H710-H721
pubmed: 30657727
J Biol Chem. 2009 Jan 9;284(2):723-7
pubmed: 18757362
Mol Med Rep. 2017 Nov;16(5):6934-6939
pubmed: 28901411
Nutr Metab (Lond). 2019 May 28;16:36
pubmed: 31149020
J Clin Med. 2021 Feb 12;10(4):
pubmed: 33673114
J Cell Mol Med. 2019 Aug;23(8):5303-5316
pubmed: 31140723
Genes Dev. 2015 Oct 1;29(19):1981-91
pubmed: 26443844
Antioxidants (Basel). 2022 Apr 15;11(4):
pubmed: 35453469
J Biol Chem. 2021 Dec;297(6):101368
pubmed: 34756890
Int J Mol Sci. 2021 Sep 10;22(18):
pubmed: 34575985
Q Rev Biophys. 1997 Nov;30(4):365-429
pubmed: 9634652
Free Radic Biol Med. 2018 Nov 1;127:145-152
pubmed: 29800653
Exp Mol Med. 2019 Dec 19;51(12):1-13
pubmed: 31857574
Acta Physiol (Oxf). 2018 Aug;223(4):e13067
pubmed: 29575758
Biochim Biophys Acta. 1990 Jan 15;1021(1):33-8
pubmed: 2153025
J Lipid Atheroscler. 2020 Jan;9(1):66-78
pubmed: 32821722
Circ Res. 2020 Feb 14;126(4):456-470
pubmed: 31896304
Redox Biol. 2021 Apr;40:101839
pubmed: 33486153
Cell Metab. 2015 Dec 1;22(6):1033-44
pubmed: 26603188
Cell Death Dis. 2018 May 11;9(5):568
pubmed: 29752433
Sci Rep. 2019 Aug 12;9(1):11613
pubmed: 31406184
J Intern Med. 2018 Nov;284(5):478-491
pubmed: 29331057
Int Immunopharmacol. 2021 May;94:107487
pubmed: 33636560
Biomolecules. 2021 Oct 22;11(11):
pubmed: 34827565
Circ Res. 1964 Oct;15:320-6
pubmed: 14220888
Biochim Biophys Acta. 2000 May 6;1485(1):45-55
pubmed: 10802248
Antioxid Redox Signal. 2016 Apr 10;24(11):557-74
pubmed: 26866473
Diabetes. 2006 Oct;55(10):2779-87
pubmed: 17003343
Am J Physiol Cell Physiol. 2019 May 1;316(5):C583-C604
pubmed: 30758993
Magn Reson Med. 2003 Mar;49(3):417-23
pubmed: 12594743
Comp Biochem Physiol C Toxicol Pharmacol. 2019 Jul;221:68-72
pubmed: 30926402
Antioxid Redox Signal. 2020 Dec 10;33(17):1257-1275
pubmed: 32524825
Cell Mol Life Sci. 2019 Oct;76(20):3969-3985
pubmed: 31218451
Analyst. 2019 Mar 21;144(6):2138-2149
pubmed: 30742170
PLoS One. 2019 Dec 20;14(12):e0226696
pubmed: 31860682
J Cell Physiol. 2017 Nov;232(11):3020-3029
pubmed: 28500736
Cardiovasc Res. 2022 Jan 7;118(1):115-129
pubmed: 33210138
Br J Pharmacol. 2009 May;157(2):195-206
pubmed: 19309362
Sci Rep. 2019 Mar 14;9(1):4496
pubmed: 30872693
J Cell Biochem. 2019 Mar;120(3):3651-3663
pubmed: 30259999
Exp Ther Med. 2017 May;13(5):2143-2150
pubmed: 28565821
Science. 2012 Aug 31;337(6098):1052-4
pubmed: 22936767
FASEB J. 2008 Jun;22(6):1756-68
pubmed: 18198219
Mediators Inflamm. 2013;2013:137579
pubmed: 23509418
Free Radic Biol Med. 2019 Dec;145:103-117
pubmed: 31553938
J Lipid Res. 2018 Jul;59(7):1084-1093
pubmed: 29627764